FeesSafety
Pluang+

Rhelion's Filament Health inks deal to supply psilocybin drug PEX010 for USC depression therapy study

Market News
15 Sep 2026
Newsfile Corp
View Source
Bullish
Rhelion's Filament Health inks deal to supply psilocybin drug PEX010 for USC depression therapy study

Rhelion Life Sciences' subsidiary Filament Health has signed a supply and licensing agreement with the University of Southern California to provide PEX010, a patented botanical psilocybin drug candidate, for a clinical study on Psilocybin Assisted Mindfulness Therapy targeting depression. This deal highlights Filament's role as a leading supplier of pharmaceutical-grade natural psilocybin, supporting over 80 research studies globally. The study aims to explore whether mindfulness meditation can enhance psilocybin therapy's effectiveness. Rhelion acquired Filament Health earlier in 2026, gaining its patents and drug candidates, positioning the company strongly in the psychedelic drug development sector.

Rhelion Life Sciences' subsidiary Filament Health's recent agreement with the University of Southern California for a psilocybin drug study provides context for health sector trading. For readers following the health sector, here is Pluang's market snapshot as of Sep 15, 2026 19:14 WIB: of 91 priced US health stocks, 28 rose and 59 fell. Notable prices include TWST at USD 133.00 with a 1-day change of -1.30%, FLNA at USD 0.73 up 1.28%, and ALC at USD 66.90 down 1.24%.

More News

Palantir projects $2.16B revenue for Q3, with recent quarters hinting even stronger results ahead.

Palantir projects $2.16B revenue for Q3, with recent quarters hinting even stronger results ahead.

Palantir has guided its revenue for the third quarter of 2026 to reach $2.16 billion. This forecast is supported by the company's performance in the last two quarters, which suggests that actual results could surpass expectations. The strong revenue ...

Company Fundamentals
Bullish
38 minutes ago
Institutional investor moves $22.86M AAVE amid sharp price drop, signaling possible sell-off.

Institutional investor moves $22.86M AAVE amid sharp price drop, signaling possible sell-off.

An institutional investor recently moved 156,690 AAVE tokens worth $22.86 million, depositing 62,000 AAVE into exchanges, likely signaling a potential sell-off or portfolio reshuffle. This large movement coincides with AAVE's ongoing sharp decline, w...

Market News
Bearish
5 hours ago
First Russian diesel tanker arrives in US under Trump-Putin deal amid rising fuel prices

First Russian diesel tanker arrives in US under Trump-Putin deal amid rising fuel prices

The first Russian diesel tanker carrying 40,000 tons has arrived in New York following a deal between President Donald Trump and Russian President Vladimir Putin to release millions of tons of diesel into the global market. This move aims to address ...

Market News
Neutral
5 hours ago
Solana wallet tools offer distinct insights but don't guarantee trading outcomes.

Solana wallet tools offer distinct insights but don't guarantee trading outcomes.

Various Solana wallet research tools serve different purposes: wallet labels classify traders, performance metrics show past activity, block explorers reveal transaction history, and swap tools prepare trades. These tools help investors analyze walle...

Protocol Fundamentals
Neutral
5 hours ago
Evernorth shifts to XRP for digital treasury, citing Bitcoin's limits for on-chain finance.

Evernorth shifts to XRP for digital treasury, citing Bitcoin's limits for on-chain finance.

Evernorth Holdings CEO Asheesh Birla announced the company is using XRP as the base for its digital-asset treasury, highlighting Bitcoin's limitations for on-chain activities. Birla explained that while Bitcoin can be moved or held, it lacks function...

Protocol Fundamentals
Bullish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App